Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Neuropsychopharmacology wikipedia , lookup
Psychopharmacology wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Drug design wikipedia , lookup
Prescription costs wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Pharmacognosy wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Chicago, Rockford, Edwardsville 312-573-8248 815-965-1106 618-656-7672 GLOSSARY of TERMS Adulterated Specimen - A specimen containing a substance that is not a normal constituent or containing an endogenous substance at a concentration that is not a normal physiological concentration. Agency - Refers to the particular agency, program, service area, etc. responsible for the Client. Analyte - A general term referring to the compound being tested. This could mean a fasting blood sugar or a specific drug. Assay - A general term referring to the testing process. Chain of Custody - The process of verifying and documenting the client's identification and labeling the specimen to insure is it only from the client, so that the test results are actually for the individual. Client - Refers to the person who is providing the specimen for testing. Collection - The process of obtaining a specimen from the Client. This may be "Observed" (actual viewing of the urination into the container) or "Supervised" (restricted access to washroom and prohibited water use). Confirmation Test - When a sample tests positive, it may indicate recent drug usage. Typically, the greater the usage, or closer to the usage time, the higher the result. However, a "false" positive can occur when certain substances cross-react with the testing process. (Example: Codeine in cough medicine versus cocaine) The Confirmation Test will "validate" the test result and well as differentiate between the actual and false values. Some agencies split the sample into two containers and reserve the second container or aliquot of the original specimen for confirmation only. (See also GC/MS) Cut-Off Value Detection Time - The approximate interval between usage and when the drug will likely appear in the urine sample. This varies with the amount used, length of time over which the drug was consumed and the amount of liquids consumed to dilute the urine or if diuretics are used. Dilute Specimen - A urine specimen with creatinine and specific gravity values that are lower than expected for human urine. Drop - Term sometimes used to refer to the collection of a urine specimen from a client. Interference - Chemicals, foods, herbs and other drugs can "interfere" with the testing. Examples of possible substances are listed in each of the specific drug information sheets. GC/MS - This abbreviation stands for Gas Chromatography / Mass Spectrometer. This instrument has the ability to physically separate various analytes (compounds) by their atomic weight and then assay their individual concentrations. Linearity - Many tests have a "Linear" relationship. This means the test equipment "readings" increase as the concentration increases. "Linear Up To" means test accuracy is at its best up to a certain level. Once above it, an error occurs with the higher the concentration of the drug. 748959060 Eff: 2/6/02 Doc. No. 18.323 Page 1 of 2 Chicago, Rockford, Edwardsville 312-573-8248 815-965-1106 618-656-7672 Metabolite - The body will break down food and drugs into smaller compounds for absorption. Fat in food for example is broken down (metabolized) into fatty acids and glycerol. Thus the fatty acids and glycerol are metabolites of fat. The same is true for the breakdown of drugs in the body. Oxidizing Adulterant - A substance that acts alone or in combination to oxidize drugs or drug metabolites to prevent detection, or effects the reagents used for the drug tests. Examples are bleach, pyridium, nitrites, halogens, peroxidase and hydrogen peroxide. Qualitative Results - The assay can only provide either a "Positive" or "Negative" result. An example is a home pregnancy test. Such assays are adequate for a rapid screening while the client is "on-site". Quantitative Results - The assay provides a number indicating the actual concentration is the analyte in the sample. This method is the most accurate assay. (Like looking into a bowl of flour and knowing exactly how much of what kind of flour (white, wheat, rye, soy, etc.) is present. SAMHSA - Refers to the Substance Abuse and Mental Health Services Administration department of the U.S. Government. (This program was formerly known as NIDA) Semi-Quantitative Results - The assay provides a number to estimate the concentration of the analyte in the sample. This estimate is very accurate when the results are well into the Negative or Positive range. (Like looking into a bowl and determining if its flour, cornstarch or salt. You know about how much is there, but not the specific kind of product. ) Specimen - Refers to the urine sample collected for testing. Substituted Specimen - A urine specimen with test gravity values that are so diminished, distorted or incongruent that they are not consistent with normal human urine. Tainted - Indicates the sample failed a component of the qualitative adulterant screening test. Threshold - This is the lower limit, cut-off or minimum point where the level detected is considered as "Positive" in qualitative or semi-quantitative assays. These cutoff levels follow the recommendations of SAMHSA. Voucher - Refers to the Chain of Custody Requisition. DOCUMENT APPROVAL: Revision History: Date Rev. No. 11/14/01 0 2/6/02 1 748959060 William J. Salas BS, MT(ASCP), NM(ASCP) - Laboratory Director (Original signed document maintained in Master Laboratory Manual) Change Description: Initial draft of the document Added Adulterated and diluted specimens and oxidizing agents Eff: 2/6/02 Doc. No. 18.323 Author: Bill Salas Bill Salas Page 2 of 2